LUNG financial statements and SEC filings
LUNG annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $90.50M | -$53.66M | -$54.00M | 10-K |
| 2024-12-31 | $83.79M | -$57.70M | -$56.39M | 10-K |
| 2023-12-31 | $68.67M | -$61.94M | -$60.84M | 10-K |
| 2022-12-31 | $53.66M | -$58.64M | -$58.92M | 10-K |
| 2021-12-31 | $48.42M | -$47.30M | -$48.66M | 10-K |
| 2020-12-31 | $32.73M | -$32.33M | -$32.23M | 10-K |
LUNG annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $129.29M | $75.17M | $54.12M | 10-Q |
| 2024-12-31 | $162.85M | $77.04M | $85.81M | 10-K |
| 2023-12-31 | $177.78M | $59.47M | $118.31M | 10-K |
| 2022-12-31 | $193.68M | $39.67M | $154.01M | 10-K |
| 2021-12-31 | $235.17M | $41.93M | $193.24M | 10-K |
| 2020-12-31 | $263.71M | $37.57M | $226.13M | 10-K |
LUNG annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | -$32.38M | -$452.00K | $833.00K | 10-K |
| 2024-12-31 | -$31.54M | -$1.45M | $1.36M | 10-K |
| 2023-12-31 | -$37.61M | -$807.00K | $21.40M | 10-K |
| 2022-12-31 | -$45.08M | -$1.32M | $2.42M | 10-K |
| 2021-12-31 | -$41.39M | -$3.67M | $4.46M | 10-K |
| 2020-12-31 | -$30.63M | -$911.00K | $234.83M | 10-K |